SLXN Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Silexion Therapeutics Corp (SLXN) is not a good buy for a beginner, long-term investor at this moment. The stock lacks positive trading signals, has weak financial performance, and no recent news or catalysts to drive growth. The technical indicators suggest bearish momentum, and the absence of significant hedge fund, insider, or congressional trading activity further diminishes confidence in the stock's near-term potential.
The stock is showing bearish momentum with MACD below 0 and negatively contracting, RSI at 26.517 in the neutral zone, and bearish moving averages (SMA_200 > SMA_20 > SMA_5). The price is trading below the pivot level of 1.104, with key support at 0.993 and resistance at 1.214.
NULL identified. No recent news, congressional trading, or hedge fund activity to indicate positive sentiment.
Weak financial performance with negative net income and declining EPS. No recent insider or hedge fund activity, and technical indicators suggest bearish momentum.
In Q4 2025, revenue was $0 with no growth YoY. Net income improved but remains negative at -$4.41M. EPS dropped significantly by -90.12% YoY, and gross margin remains at 0%.
No analyst rating or price target changes available.
